How does saffron work for depression?

Saffron exerts its antidepressant effects primarily through the modulation of brain chemistry. Its active compounds, specifically crocin and safranal, function as serotonin reuptake inhibitors, increasing the availability of serotonin, dopamine, and norepinephrine in the synaptic cleft. Additionally, these compounds offer neuroprotective antioxidant benefits. Evidence Level B clinical trials suggest this mechanism makes saffron comparable to standard antidepressant medications like fluoxetine for mild to moderate depression.

Can I take saffron with antidepressants or blood thinners?

Caution is strongly advised when combining saffron with prescription medications. Because saffron increases serotonin levels, taking it concurrently with SSRIs or MAOIs may increase the risk of serotonin syndrome. Furthermore, saffron possesses mild anticoagulant properties, meaning it may enhance the effects of blood-thinning medications like warfarin or aspirin, increasing the risk of bleeding. Always consult a physician before adding saffron to a regimen involving these drugs.

What is the recommended daily dosage of saffron for depression?

The standard therapeutic dosage for depression in adults is 15 to 30 mg of standardized saffron extract daily. Clinical trials supporting this dosage (Evidence Level B) typically divide the intake into two doses, such as 15 mg twice daily. It is critical not to exceed 5 grams (5,000 mg) in a single dose, as this level is associated with acute toxicity and severe adverse reactions.

Is saffron safe to take during pregnancy?

Saffron is considered unsafe for medicinal use during pregnancy. High doses possess abortifacient properties, meaning they can stimulate uterine contractions and potentially induce miscarriage or premature labor. While trace amounts used as a culinary spice in food are generally recognized as safe, pregnant women should strictly avoid saffron supplements or extracts. Due to insufficient safety data, breastfeeding women are also advised to avoid medicinal doses.

What are the common side effects of taking saffron supplements?

When taken at recommended dosages, saffron is generally well-tolerated, though some users report mild side effects including dry mouth, nausea, dizziness, and headache. At very high doses, toxicity can occur, resulting in severe symptoms such as vomiting, anxiety, low blood pressure, and bleeding issues. Individuals with bipolar disorder should avoid saffron, as it may trigger manic episodes.

Safran (Crocus sativus)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Saffron (Crocus sativus) is a medicinal plant and spice with documented antidepressant, neuroprotective, and antioxidant properties [PMID:35276955, PMID:30568374].

Contexte

Saffron is derived from the dried stigmas of the Crocus sativus L. flower, a perennial herb originally cultivated in the East, Middle East, and Mediterranean countries [PMID:35276955, PMID:30568374, PMID:39064764].

Usages traditionnels

Traditionally used as a spice, coloring agent, and medicinal herb to promote blood circulation, remove blood stasis, cool and detoxify blood, relieve depression, and calm the mind [PMID:37114174, PMID:34544335]. Historical texts such as Razi's Al-Hawi mention its use as a diuretic, analgesic, anti-inflammatory, hepatoprotective, appetite suppressant, hypnotic, antidepressant, and bronchodilator [PMID:26877844].

Composés actifs

The primary bioactive compounds are carotenoids including crocins and crocetin, as well as picrocrocin and safranal [PMID:35276955, PMID:30568374, PMID:37675158]. Other components include anthocyanins, flavonoids, and terpenoids [PMID:34544335].

Mécanisme d'action

Saffron exerts effects through antioxidant, anti-inflammatory, and neuroprotective activities [PMID:35276955, PMID:35911474]. Antidepressant mechanisms include neurotransmitter regulation, inhibition of monoamine oxidase type A and B, inhibition of monoamine reuptake, N-methyl-d-aspartate antagonism, and improvement of brain-derived neurotrophic factor signaling [PMID:39351321, PMID:35408474]. It also interacts with the Nrf2 signaling pathway to combat oxidative stress and inflammation [PMID:36033950].

Preuves cliniques

Preuve AMajor Depression

Saffron was confirmed to be effective for the treatment of major depression, showing large treatment effects in placebo-comparison trials and comparable effectiveness to standard medications for mild to moderate depression [PMID:25384672, PMID:39351321, PMID:40416274].

Preuve AADHD

Saffron demonstrates promise in improving ADHD symptoms as either a single therapy or an adjuvant to methylphenidate (MPH) [PMID:37864351].

Preuve AAlzheimer's Disease / Cognitive Impairment

Clinical trials demonstrated saffron was more effective than placebo and as effective as donepezil in treating Alzheimer's disease [PMID:24848002]. A systematic review of RCTs found it well-tolerated in patients with MCI/AD [PMID:32445136].

Preuve BSubclinical Depressive Symptoms

A randomized, double-blind, placebo-controlled trial examined 28 mg daily of saffron extract (Affron) for mood and sleep in adults [PMID:40414301].

Sécurité et effets indésirables

Saffron is generally reported to have an acceptable safety profile and lower incidence of side effects compared to conventional drugs [PMID:37864351, PMID:39351321]. In vitro LD50 is 200 mg/ml and in animal studies it is 20.7 g/kg [PMID:26468457].

Posologie et administration

Clinical trials have utilized dosages such as 20-30 mg/day for ADHD in children [PMID:30741567] and 28-30 mg/day for depression in adults [PMID:40414301, PMID:40416274]. No PubMed data available. Consult a healthcare provider.

Synthèse des preuves

The evidence for saffron is strongest (Level A) for the treatment of depression and cognitive impairment due to multiple systematic reviews and meta-analyses of RCTs. Evidence for ADHD is promising based on a systematic review. Other applications (diabetes, cancer, ocular diseases) are primarily supported by reviews of preclinical or limited clinical data.

Sources PubMed

1.PMID: 37864351 (2024) — The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review. · Journal of attention disorders
2.PMID: 35276955 (2022) — Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases. · Nutrients
3.PMID: 25384672 (2014) — Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. · Human psychopharmacology
4.PMID: 38424688 (2024) — New horizons for the study of saffron (Crocus sativus L.) and its active ingredients in the management of neurological and psychiatric disorders: A systematic review of clinical evidence and mechanisms. · Phytotherapy research : PTR
5.PMID: 40414301

Safran

Sources et citations

Hops

Lemon Balm

St. John's Wort

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Posologie et administration

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Safran

Sources et citations

Plantes associées

Hops

Lemon Balm

St. John's Wort

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Posologie et administration

Synthèse des preuves

Sources PubMed

Sources gouvernementales